tirzepatide discontinued We have temporarily offering due to recent regulatory changes. The FDA has declared the shortage of Tirzepatide resolved, leading to the prohibition of compounded versions of the drug. If you're ⚠️Medicine shortage update - Discontinuation

[4] Crucially for weight management, these drugs act on receptors in the brainparticularly in the hypothalamus and brainstemto reduce appetite and increase feelings of satiety

Rather than simply reducing caloric intake through appetite suppression, glucagon increases energy expenditure directly

For more options that promote recovery, detox, and overall cellular health, explore our full range of antioxidant and recovery peptides available in Canada

These mechanisms represent biologically plausible explanations, not established causal pathways, and should be interpreted as context for clinical vigilance rather than confirmed pharmacological certainty

Inhibition of glucagon: GLP-1 inhibits the release of glucagon, another hormone produced by the pancreas

Although Ozempic and some weight loss medications share the same active ingredient, Ozempic is approved solely for addressing type 2 diabetes, not for weight loss